Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Budesonide/procaterol

Next Previous
X
Search
Drug Profile

Budesonide/procaterol

Alternative Names: Procaterol/budesonide; SYN-006; Synbitide HFA MDI

Latest Information Update: 24 Mar 2017

Price :

$50 *

Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Intech Biopharm
  • Class Antiasthmatics; Bronchodilators; Ethanolamines; Glucocorticoids; Hydroxyquinolines; Pregnenediones; Small molecules
  • Mechanism of Action Beta 2 adrenergic receptor agonists; Steroid receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No
  • Available For Licensing Yes

Highest Development Phases

  • Phase II Asthma

Most Recent Events

  • 24 Mar 2017 Budesonide/procaterol is still at phase II development stage for Asthma in Taiwan (Inhalation)
  • 08 Sep 2016 Intech Biopharm has patent protection for Budesonide/procaterol in USA, Canada, Australia, New Zealand, South Korea and Hong Kong (Intech Biopharm website, September 2016)
  • 08 Sep 2016 Intech Biopharm plans phase III trials for Asthma in countries worldwide (Intech Biopharm pipeline, September 2016)

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top